EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Malignant ascites in ovarian cancer: New advances and translational opportunities

Kyung Hyun Boo, Gaeun Lee, Minkyung Song

Translational Oncology · 2025-12 · 62 · 102568

DOI: 10.1016/j.tranon.2025.102568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Oncology, 2025-12. Verfasst von Kyung Hyun Boo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea, National Cancer Center, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant ascites is a defining and clinically challenging feature of advanced ovarian cancer, driving peritoneal dissemination, therapeutic resistance, and poor clinical outcomes. Beyond its traditional description as a protein-rich fluid, high-resolution profiling now reveals ascites as an active ecosystem that enforces vascular leakage, creates dynamic interactions among cellular, acellular, and environmental components, fuels cellular reprograms, and builds profound immune suppression. In this review, we first synthesize established knowledge on ascites formation and composition, and then delineate how this milieu reshapes tumor, stromal, and immune compartments, altering their fate and function. We also integrate current diagnostics and map the therapeutic landscape spanning vascular permeability control, effective locoregional chemotherapy, cellular reprogramming, and stress/metabolic interventions, alongside palliative drainage devices. A deeper understanding of the dynamic interactions and regulatory mechanisms within malignant ascites provides a foundation for developing new therapeutic strategies to overcome its clinical challenges and improve outcomes for ovarian cancer patients.

Schlagwörter

Stichwörter der Autor:innen

Immune suppressionMalignant ascitesOvarian cancerTME reprogrammingTherapy resistance

Autor:innen und Institutionen

  • Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
  • Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea; Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Republic of Korea. Electronic address: piscesmk@sk…

Förderung

  • Ministry of Science and ICT, South Korea
  • National Cancer Center
  • National Research Foundation of Korea

Zitieren

APA

Boo, K. H., Lee, G., & Song, M. (2025). Malignant ascites in ovarian cancer: New advances and translational opportunities. Translational Oncology, 62, 102568. https://doi.org/10.1016/j.tranon.2025.102568

Vancouver

Boo KH, Lee G, Song M. Malignant ascites in ovarian cancer: New advances and translational opportunities. Translational Oncology. 2025;62:102568. doi:10.1016/j.tranon.2025.102568

BibTeX
@article{Boo2025,
  author = {Boo, Kyung Hyun and Lee, Gaeun and Song, Minkyung},
  title = {Malignant ascites in ovarian cancer: New advances and translational opportunities},
  journal = {Translational Oncology},
  year = {2025},
  volume = {62},
  pages = {102568},
  doi = {10.1016/j.tranon.2025.102568}
}
Kostenlos starten →